US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P SmallCap Health Care ETF

51.63

+0.35410.69%

Post-market: 51.640.0069+0.01%19:30 EDT

Volume:8K

Turnover:410.51K

Market Cap:175.04M

PE:- -

High:51.99

Open:51.57

Low:51.54

Close:51.28

52wk High:56.45

52wk Low:39.08

Shares:3.39M

Float Shares:3.39M

Volume Ratio:0.38

T/O Rate:0.23%

Dividend:0.00

Dividend Rate:0.01%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Twist Bioscience (TWST) and Medpace Holdings (MEDP)

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

Corcept Director James N. Wilson Disposes of $1.11 Million in Common Shares

BrightSpring PharMerica President Scott A. Greenwell Sells 15,099 Shares for $874,380.09

Alkermes Appoints Anne Whitaker to Board of Directors

Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors

THOMSON REUTERS

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU

Analysts Have Conflicting Sentiments on These Healthcare Companies: Molina Healthcare (MOH), High Tide (HITI) and Cullinan Management (CGEM)

Barclays downgrades Scholar Rock on valuation after FDA approval

Biofrontera announces FDA approval of Ameluz supplemental new drug application

Scholar Rock Wins FDA Approval for SMA Therapy

Scholar Rock price target raised to $84 from $76 at BMO Capital

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

Scholar Rock announces FDA approval of isembyld

Pharming wins FDA nod to extend Joenja use to younger APDS children

“大空头”伯里转向防守：清仓科技股看跌期权，增持现金应对市场动荡

Alkermes Announces Launch of 9TH Annual Alkermes Pathways Research Awards® Program

THOMSON REUTERS

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/PSCH/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PSCH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSCH\",,,,,undefined,":{"symbol":"PSCH","market":"US","secType":"STK","nameCN":"Invesco S&P SmallCap Health Care ETF","latestPrice":51.6331,"timestamp":1790971200000,"preClose":51.279,"halted":0,"volume":7949,"hourTrading":{"tag":"盘后","latestPrice":51.64,"preClose":51.6331,"latestTime":"19:30 EDT","volume":9,"amount":464.6324,"timestamp":1790983802989,"change":0.0069,"changeRate":0.000134,"amplitude":0},"delay":0,"changeRate":0.006905360868971614,"floatShares":3390000,"shares":3390000,"eps":0,"marketStatus":"Market Closed","change":0.3541,"latestTime":"10-02 16:00:00 EDT","open":51.57,"high":51.99,"low":51.54,"amount":410508.641047,"amplitude":0.008776,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":51.279,"sharesOutstanding":3220000,"nav":51.29067,"aum":175109072.55,"dividendRate":0.000058,"bidAskSpread":0.001911,"postHourTrading":{"tag":"盘后","latestPrice":51.64,"preClose":51.6331,"latestTime":"19:30 EDT","volume":9,"amount":464.6324,"timestamp":1790983802989,"change":0.0069,"changeRate":0.000134,"amplitude":0},"volumeRatio":0.3820202063487071,"impliedVol":0.1092,"impliedVolPercentile":0.7371},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSCH\",,,,,undefined,":{"symbol":"PSCH","floatShares":3390000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3820202063487071,"shares":3390000,"dividePrice":0.003,"high":51.99,"amplitude":0.008776,"preClose":51.279,"low":51.54,"week52Low":39.08,"pbRate":"--","week52High":56.454,"institutionHeld":0,"latestPrice":51.6331,"eps":0,"divideRate":0.000058,"volume":7949,"delay":0,"ttmEps":0,"open":51.57,"prevYearClose":44.0553,"prevWeekClose":52.7945,"prevMonthClose":52.07,"prevQuarterClose":52.07,"fiveDayClose":52.7945,"twentyDayClose":54.7539,"sixtyDayClose":54.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSCH\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"PSCH","amount":0.00033,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-09-22","symbol":"PSCH","amount":0.00259,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PSCH","amount":0.00199,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-24","symbol":"PSCH","amount":0.01419,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSCH","amount":0.01801,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"Invesco S&P SmallCap Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSCH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.01949,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00522,"currency":"USD"},{"executeDate":"2022-03-31","recordDate":null,"paymentDate":"2022-03-31","value":3,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.00448,"currency":"USD"},{"executeDate":"2024-03-18","recordDate":"2024-03-19","paymentDate":"2024-03-22","value":0.03613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSCH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSCH\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668996274","title":"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Twist Bioscience (TWST) and Medpace Holdings (MEDP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668996274","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668996274?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:30","pubTimestamp":1789648219,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alkermes (ALKS), Twist Bioscience (TWST) and Medpa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-twist-bioscience-twst-and-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-twist-bioscience-twst-and-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065169927.USD","WDNA","FBT","LABU","TWST","LU0128526141.USD","IBRN","XBI","ALKS","LU2065170008.USD","BK4585","BK4139","PSIL","HCSG","PSCH","BK4581","IDNA","LU2065171311.SGD","ARKG","XLV","GNOM","BK4137","BK4588","MEDX","MEDP","LU2065171402.SGD","BK4121","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668996120","title":"Nuvation Bio announces FDA approval of sNDA for Ibtrozi","url":"https://stock-news.laohu8.com/highlight/detail?id=2668996120","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668996120?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:35","pubTimestamp":1789644932,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) announced that the U.S. FDA has approved a supplemental New Drug Application for Ibtrozi, a ROS1 inhibitor approved for the tre...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","RSPH","GNMX","LFSC","XLVX","PINK","NVIB","SYNB","MRNY","IBB","IYH","PSCH","BK4588","MEDI","GDOC","BK4007","TECB","IEIH","NUVB","FRTY","BMED","BK4585","TBXU","BBP","LABU","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963474","title":"Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963474","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963474?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:30","pubTimestamp":1789637420,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that theFDA approved Kerendia to reduce urinary albumin-to-creatinine ratio, which is expected to reduce the risk of sustai...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NVIB","GNMX","MRNX","MEDI","IDNA","PINK","BK4588","SYNB","GDOC","BBP","LABU","PSCH","BMED","FRTY","TBXU","TECB","MRNY","IYH","XLVX","BAYRY","LFSC","IEIH","IBB","RSPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668693589","title":"Corcept Director James N. Wilson Disposes of $1.11 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2668693589","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668693589?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:31","pubTimestamp":1789590707,"startTime":"0","endTime":"0","summary":"Corcept director James N. Wilson disposes of $1.11 million in common sharesCorcept director James N. Wilson reported selling 10,000 common shares on Sept. 15, 2026.Sales prices ranged from USD 110.27 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL5LXKps:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Corcept Director James N. Wilson Disposes of $1.11 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CORT","FBT","LU1559883803.SGD","BK4532","PSCH","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668927933","title":"BrightSpring PharMerica President Scott A. Greenwell Sells 15,099 Shares for $874,380.09","url":"https://stock-news.laohu8.com/highlight/detail?id=2668927933","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668927933?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:05","pubTimestamp":1789589131,"startTime":"0","endTime":"0","summary":"BrightSpring PharMerica President Scott A. Greenwell sells 15,099 shares for $874,380.09Scott A. Greenwell, President of PharMerica, sold 15,099 BrightSpring Health Services common shares on Sep. 14 a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL8GK2fp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BrightSpring PharMerica President Scott A. Greenwell Sells 15,099 Shares for $874,380.09","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4196","LU2089984988.USD","PSCH","LU2468319806.SGD","PTH","BTSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607455","title":"Alkermes Appoints Anne Whitaker to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607455","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607455?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:00","pubTimestamp":1789556448,"startTime":"0","endTime":"0","summary":"Alkermes appoints Anne Whitaker to board of directorsAlkermes appointed Anne C. Whitaker as an independent director to its board.Whitaker is a biopharmaceutical executive with commercial, operational,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL86gXCW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","PSIL","BK4139","IBRN","FBT","PSCH","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607123","title":"Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607123","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607123?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:00","pubTimestamp":1789556400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA78XSXG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IBRN","PSIL","ALKS","PSCH","FBT","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671746","title":"ASX biotech expands diagnostics portfolio after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671746","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667671746?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488000,"startTime":"0","endTime":"0","summary":"Telix Pharmaceutical’s (ASX.TLX) Pixclara becomes the first positron emission tomography, or PET, imaging agent for glioma brain cancer to receive approval from the US Food and Drug Administration.Why","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["RSPH","MEDI","BBP","SYNB","TBXU","IYH","BMED","XBIX","IDNA","GNMX","GDOC","FRTY","MRNY","PSCH","LABU","TECB","XLVX","BK4585","NVIB","MRNX","IBB","LFSC","BK4588","PINK","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644374","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Molina Healthcare (MOH), High Tide (HITI) and Cullinan Management (CGEM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644374","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644374?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:40","pubTimestamp":1789472436,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Molina Healthcare (MOH), High Tide (HITI) and Cull...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-molina-healthcare-moh-high-tide-hiti-and-cullinan-management-cgem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-molina-healthcare-moh-high-tide-hiti-and-cullinan-management-cgem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4154","BK4588","LABU","BK4139","XLV","SG9999014039.USD","BK4532","SG9999014013.SGD","CGEM","HITI","BK4585","BK4581","PSCH","SG9999014005.SGD","BK4007","SG9999014021.USD","MOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643557","title":"Barclays downgrades Scholar Rock on valuation after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667643557?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:10","pubTimestamp":1789463419,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout downgraded Scholar Rock (SRRK) to Equal Weight from Overweight with a price target of $58, up from $55. The approval ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","GNMX","MEDI","IDNA","PINK","TACU","SYNB","GDOC","BBP","PSCH","LABU","BMED","FRTY","TBXU","TECB","MRNY","IYH","XLVX","TSPA","LFSC","IEIH","CDIG","IBB","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","TECB","BMED","LABU","IEIH","SYNB","GNMX","XLVX","IYH","NVIB","PINK","MEDI","BBP","MRNY","BK4585","BFRI","IDNA","BK4007","LFSC","MRNX","RSPH","BK4588","GDOC","PSCH","FRTY","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066661","title":"Scholar Rock Wins FDA Approval for SMA Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"The latest update is out from Scholar Rock Holding ( ($SRRK) ). On September 11, 2026, Scholar Rock announced U.S. FDA approval of ISEMBYLD (apiteg...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","XLVX","BK4585","PINK","LFSC","IEIH","GNMX","MRNY","FRTY","BK4588","GDOC","PSCH","BMED","BBP","IBB","MEDI","LABU","MRNX","IDNA","IYH","SYNB","NVIB","TECB","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECB","XLVX","MRNX","PINK","TBXU","SYNB","GNMX","GDOC","THNR","PSCH","BBP","MEDI","LABU","IDNA","BMED","BK4585","BK4588","MRNY","BK4139","IBRN","SRRK","FRTY","LFSC","IBB","IYH","NVIB","RSPH","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635862","title":"Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635862","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635862?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:54","pubTimestamp":1789340092,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA approval for Pixclara, the first FET-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4179","MRNY","TECB","FRTY","MRNX","IBB","MEDI","BK4139","IDNA","NVIB","TBXU","PINK","BMED","FET","GNMX","GDOC","SYNB","BBP","BK4588","LABU","TLX","LFSC","IYH","RSPH","BK4585","PSCH","IEIH","XLVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","MRNX","GDOC","IYH","FRTY","IEIH","LFSC","SRRK","BK4139","TECB","MEDI","NVIB","TBXU","BK4585","LABU","THNR","SYNB","RSPH","IDNA","GNMX","PINK","PSCH","MRNY","BMED","BK4588","BBP","XLVX","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666795715","title":"Pharming wins FDA nod to extend Joenja use to younger APDS children","url":"https://stock-news.laohu8.com/highlight/detail?id=2666795715","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666795715?lang=en_us&edition=fundamental","pubTime":"2026-09-12 02:32","pubTimestamp":1789151567,"startTime":"0","endTime":"0","summary":"Pharming Group ( ($NL:PHARM) ) has provided an announcement. Pharming has secured U.S. FDA approval for new 40 mg and 50 mg twice-daily doses of Jo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","BK4585","PINK","NVIB","PSCH","TBXU","BK4588","IBB","MRNY","SYNB","GDOC","GNMX","BMED","XLVX","LFSC","LABU","IYH","FRTY","MEDI","TECB","RSPH","BBP","IEIH","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154180259","title":"“大空头”伯里转向防守：清仓科技股看跌期权，增持现金应对市场动荡","url":"https://stock-news.laohu8.com/highlight/detail?id=1154180259","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154180259?lang=en_us&edition=fundamental","pubTime":"2026-09-11 11:54","pubTimestamp":1789098872,"startTime":"0","endTime":"0","summary":"知名投资者、电影《大空头》原型迈克尔·伯里周三透露，他已全面削减所有持仓的风险敞口，并平掉了2026年12月到期的英伟达（NASDAQ: NVDA）和Palantir Technologies Inc.（NASDAQ:...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDB","IE00B5TLWC47.USD","LU0133085943.USD","SGXZ51526630.SGD","EFIV","SOXS","HK0000320223.HKD","LU0985489474.SGD","LU2471134879.HKD","IE00BMPRXR70.SGD","NVYY","SG9999015952.SGD","LU0320765059.SGD","LU2249611893.SGD","SOXL","IE00BJTD4N35.SGD","LU1645745479.HKD","TDIV","LU1244550494.USD","LU0898699433.AUD","BK4614","LU0157215616.USD","LU0528227936.USD","IE0002270589.USD","LU0080751232.USD","LU0557290698.USD","LU1815333072.USD","BK4534","SOXQ","BK4023","LU0354030511.USD","NBIG","LU2148611432.USD","LU0068578508.USD","LU2294711713.HKD","LU0431992006.USD","IE0009G5SDU7.USD","LU0353189763.USD","LU2417539215.USD","LU0174119429.USD","LU1923623000.USD","SOXX","IETC","EYES","LU0979878070.USD","IE00B19Z8W00.USD","LU2552382215.SGD","SG9999004303.SGD","LU0289960550.SGD","LU2357305700.SGD","LU0456842615.SGD","PSCH","LU2168564222.USD","LU1989764664.SGD","LU2054465674.USD","LU0726765562.USD","IE0004086264.USD","IE00B3S45H60.SGD","LU2462591277.SGD","NVII","BK4154","SHLD","LU2271345857.HKD","LU0476273544.USD","IE00B19Z3581.USD","LU0708995401.HKD","LU2237957902.USD","LU0077335932.USD","BK4554","LU1935042991.SGD","IE00BHPRN162.USD","FDTX","SORCL2609","HK0000819398.USD","LU1064131342.USD","LU0965509101.SGD","LU1974910355.USD","LU1988902786.USD","LU2028103732.USD","LU0061474960.USD","LU2250418816.HKD","LU1116320737.USD","THMR","LU2125909593.SGD","BK4605","IE00BGV7N243.SGD","SG9999014575.USD","LU0225283273.USD","IE000KEQY171.SGD","LU1852331112.SGD","LU1979441026.SGD","IE00B1XK9C88.USD","LU2092937148.SGD","SPLTRmain","LU0107464264.USD","SG9999014906.USD","LU0672654240.SGD","LU2347655156.SGD","LU2458330243.SGD","SNPE","LU1861217088.USD","LU0210535034.USD","LU0069063385.USD","LU2168564495.EUR","LU0128525929.USD","LU1868837136.USD","LU0787776722.HKD","LU0109391861.USD","LU0964807845.USD","LU0466842654.USD","LU0050427557.USD","LU2750360997.AUD","IE00BN29S564.USD","IE00B775SV38.USD","NVDD","LU2860962120.EUR","LU1934455277.USD","LU2290526834.HKD","LU0316494557.USD","LU2430703095.HKD","LU1868837300.USD","XLK","ORAC","LU1153585028.USD","GB00BDT5M118.USD","LU1732800096.USD","HK0000914660.USD","LU1323610961.USD","HK0000304805.HKD","VT","LU1815336760.USD","LU2357125470.USD","NEBX","SG9999015341.SGD","LU0079474960.USD","LU0267386448.USD","LU1720051108.HKD","NVC","NVDX","LU0175139822.USD","LU2047632596.USD","LU2077746001.SGD","LU2750360641.GBP","LU0097036916.USD","LU0545039389.USD","SG9999001424.SGD","LU0345770308.USD","LU1642822529.SGD","LU2954938101.SGD","LU1435385759.SGD","LU2236285917.USD","LU2355687059.USD","BK4503","BK4613","BK4220","IE00BFSS7M15.SGD","IE00BDCRKT87.USD","ORCS","PLTU","USXF","PLTI","IE00B3M56506.USD","ORCL","LU0648001328.SGD","IE00B8L5B284.USD","BK4551","LU1232071149.USD","IE0034235303.USD","IE00B8HQ1Z84.USD","LU2360107671.USD","IE00BKPKM429.USD","IE0005OL40V9.USD","LU1400636657.SGD","LU0552385451.USD","BK4587","LU1551013425.SGD","LU0048584097.USD","LU0208291251.USD","LU1316542783.SGD","SG9999014898.SGD","IE00BLSP4239.USD","LU0256863902.USD","NVDL","LU0861579265.USD","LU2361044865.SGD","PLTG","LU2023250330.USD","LU2381873111.SGD","LU0823434740.USD","LU1868837722.USD","LU2413666699.HKD","PLTL","LU0187121727.USD","BK4566","IE00BD6J9T35.USD","LU1267930573.SGD","LU0820561909.HKD","LU1670756490.USD","LU1861215975.USD","LU0265550359.USD","LU1923622614.USD","LU1935042215.USD","LU2452424414.USD","TTXU","SMH","LU1571399168.USD","SORCLmain","LU1868837565.USD","LU2097344357.USD","IE00BJJMRY28.SGD","LU2461242641.AUD","2NVD.UK","IE00B0169N27.USD","LU0820562030.AUD","NVDS.UK","IE00B0JY6N72.USD","LU1244550221.USD","IE00B894F039.SGD","LU2462591350.SGD","LU2286300806.USD","SG9999015986.USD","LU1623119135.USD","ARTY","LU1366333091.USD","LU1861127337.USD","LU2106854487.HKD","SG9999014039.USD","LU0310799852.SGD","IE00B19Z9505.USD","SHOC","LU0683600562.USD","LU2237443622.USD","LU0158827781.USD","LU1267930490.SGD","IE00BZ1G4Q59.USD","LU0289739343.SGD","LU0786609619.USD","LULG","LU1069344957.HKD","LU2279701549.SGD","ORCU","SG9999002224.SGD","CLSE","LU1429558221.USD","LU1989772840.SGD","IGV","LU0957791311.USD","LU0788109477.HKD","09388","IE00BZ199S13.USD","LU1127390331.HKD","LU2272731782.SGD","LU2463028550.USD","LU0096362180.USD","BK4528","BK4612","LU0211327993.USD","OGIG","LU1119994496.HKD","IE000ITXATA3.USD","PLTY","LU0256863811.USD","LU1861220207.SGD","LU3102509885.SGD","LU0143551892.USD","LU1803068979.SGD","LU0342679015.USD","LU1992135399.USD","LU2087625088.SGD","LU2322448957.HKD","LU0210536198.USD","LU0198837287.USD","LU0689472784.USD","BK4598","LU0417517546.SGD","LU1989764748.USD","LU2063271972.USD","LU2543165471.USD","NVDA","PLTR","ANV","LU2505996509.AUD","LU0444971666.USD","HK0000532082.HKD","BK4549","LU0210528500.USD","LU1046421795.USD","BK4579","BK4097","LU2108987350.USD","LU2471134796.USD","LU2089283258.USD","LU2237438978.USD","LU1914381329.SGD","LU2487616109.SGD","LU1202635105.USD","IE00BDRTCR15.USD","AIFD","LU2083900584.USD","LU2168563687.JPY","LU0823421333.USD","LU2089284900.SGD","LU1069347547.HKD","LU2125909916.SGD","LU0143863784.USD","LU0949170772.SGD","LU1267930730.SGD","LU1778281490.HKD","LU0323240290.USD","IE0001KFT4U8.USD","IE0004445015.USD","LU1066051225.USD","LU2473716301.USD","NVDU","SGXZ80539844.SGD","LU2756315318.SGD","LU2360032135.SGD","SMHX","LU2360106780.USD","SG9999014914.USD","IE000W1ABFV2.USD","LU1699723380.USD","LU0348723411.USD","LU2272731865.HKD","BK4529","BK4533","LU0531971165.HKD","BK4538","LU0878866978.SGD","LU1116320901.HKD","LU2896262040.SGD","LU1814569148.SGD","LU1868836914.USD","LU2125154778.USD","LU0053687314.USD","LU0320765489.SGD","LU2505996681.GBP","LU0106959298.USD","LU2420271590.USD","LU2065169927.USD","LU2999663052.SGD","LU2602419157.SGD","IE00B4YYXB79.USD","LU1366192091.USD","DIPS","LU2433249047.HKD","LU0511384066.AUD","LU1035773651.USD","LU0109392836.USD","LU2087621335.USD","LU1935042488.USD","PLTA","LU0210533765.USD","LU0323239441.USD","LU2065171311.SGD","IE00B19Z9Z06.USD","SOXY","LU1732799900.SGD","LU0329931173.USD","TRFK","LU0061474705.USD","LU0390134368.USD","BK4609","LU2065171402.SGD","LU2168564065.EUR","LU0203201768.USD","LU1868836757.USD","IE00B19Z3B42.SGD","LU0081259029.USD","LU0345768153.USD","LU2237443465.HKD","LU1880398554.USD","3NVD.UK","LU2242650005.HKD","LU2403377893.USD","SGXZ99366536.SGD","LU1242518857.USD","PLTW","LU0154236417.USD","LU2092627202.USD","NBIC","ABFL","IE0034235188.USD","LU2456880835.USD","LU1861558580.USD","BK4202","LU1839511570.USD","LU0980610538.SGD","LU2097829019.USD","LU2133065610.SGD","GUNZ","BK4141","LU1066053197.SGD","SG9999015945.SGD","LU1037948897.HKD","IE00B19Z8X17.USD","LU0345769631.USD","ONLN","LU0823414551.USD","SG9999015978.USD","SG9999017495.SGD","SGXZ81514606.USD","LU2244417387.USD","IE00BQXX3C00.GBP","HK0000304797.USD","PLT","LU0251132253.USD","LU2360107168.USD","LU1983260115.SGD","LU0094547139.USD","LU2168564149.EUR","09788","LU0310800379.SGD","LU0889565833.HKD","LU2065170008.USD","IE0004091025.USD","LU0006306889.USD","NVDO","LU0070302665.USD","07388","LU0082616367.USD","IE00BMPRXQ63.HKD","LU0868486357.SGD","LU2242649171.HKD","BK4608","IE00B7SZLL34.SGD","LU2111349929.HKD","LULU","LU0130102774.USD","FAI","LU2023251221.USD","IE0003U64NQ7.SGD","SG9999000418.SGD","LU0345770993.USD","LU1674673428.USD","IE00BKVL7J92.USD","LU0444973449.USD","SG9999014005.SGD","LU1674673691.USD","SNVD.UK","LU0070217475.USD","LU2462157665.USD","LU1861220033.SGD","LU2471134523.USD","IE00BYXW3230.USD","LU1917777945.USD","LU1145028129.USD","LU2413666426.HKD","LU2347655073.USD","LU0215105999.USD","LU2491049909.HKD","LU1951200564.SGD","IE00B1BXHZ80.USD","LU2592432038.USD","LU1868838027.USD","LU1633808545.USD","LU2430703178.SGD","LU1823568750.SGD","LU1261432733.SGD","LU0011850046.USD","SGXZ23171101.USD","LU2211815571.USD","LU1691799644.USD","BK4581","LU1935043023.USD","IE00BBT3K403.USD","LU1084165304.USD","LU1935043452.HKD","LU2458330169.SGD","IE00B1B80R65.USD","PLOO","LU0124676726.USD","SG9999014559.SGD","PLTZ","LU0323591593.USD","LU0494093205.USD","LU1821325948.USD","SG9999011175.SGD","SG9999014567.USD","BK4527","LU1144417596.USD","MELI","NBIZ","LU2931357623.SGD","LU0708994859.HKD","BK4588","LU1934455194.USD","LU0138981039.USD","LFGY","NVIW.SI","IE00BMPRXN33.USD","HK0000306701.USD","IE0009356076.USD","LU0274383776.USD","LU1506573853.SGD","IE00B7KXQ091.USD","IE00B19Z9P08.USD","LU1720051017.SGD","LU0029864427.USD","LU0433182093.SGD","SG9999018857.SGD","LU2272731600.USD","NVD2.UK","LU1721428933.USD","LU0882574139.USD","LU1992135472.HKD","LU0724617625.USD","LU2491050071.SGD","CNEQ","LU1923622291.USD","LU0950373646.USD","LU0170899867.USD","LU0912757837.SGD","IE00BJJMRX11.SGD","LU0354030438.USD","LU0719512351.SGD","LU1496350502.SGD","IE000YTNTUN2.SGD","IE00B775H168.HKD","IE00BLSP4452.SGD","LU0096364046.USD","LU0347712357.USD","LU2756315664.SGD","NVD","TYLG","LU0738911758.USD","USD","LU0127658192.USD","LU0106261372.USD","LU1244550577.SGD","LU2637965513.SGD","CHAT","SG9999002232.USD","WISE","ORCX","LU0345769128.USD","LU0943347566.SGD","LU1861559042.SGD","JGRO","LU2237443549.SGD","LU2237443978.SGD","LU0203202063.USD","LU0823421416.USD","LU0238689110.USD","NBIL","LU1280957306.USD","PLYY","LU1066051811.HKD","LU0965508806.USD","LU0820561818.USD","IE00B3SWFQ91.USD","IE000Q6AESB8.SGD","LU0823431563.USD","LU1242518931.SGD","LU2264538146.SGD","LU0266013472.USD","LU0985320562.USD","LU2279689827.SGD","LU1718418525.SGD","LU2506951792.HKD","LU2552382132.HKD","LU0308772762.SGD","LU0823414478.USD","LU0234572021.USD","BK4122","LU2326559502.SGD","LU2125909247.SGD","HK0000914686.HKD","LU2430703251.USD","GAMR","IE00BWXC8680.SGD","LU0689626769.HKD","LU1868836591.USD","LU0942090050.USD","NVDS","BK4548","BK4543","LU2552382058.USD","LU0532187761.SGD","LU1951198990.SGD","LU2023250504.SGD","LU0061475181.USD","LU2746668974.SGD","MOH","NULC","PTIR","METV","VGT","LU2213496289.HKD","ESUM","BK4532","LU0642271901.SGD","LU0957808578.USD","IE00BFSS8Q28.SGD","NVDQ","BK4077","LU0472753341.HKD","LU0868494708.USD","LU1791710400.SGD","LU0965509010.AUD","LU0057025933.USD","LU1066051498.USD","BK4516","LU1880398471.USD","LU0053666078.USD","IE00B5949003.HKD","ROM","LU0661504455.SGD","LU0823434583.USD","LU1235294995.USD","ESLG","LU1400636574.HKD","SPTE","LU2361045086.USD","IE00BKDWB100.SGD","LU2089985449.USD","SG9999015358.SGD","LU2746668461.USD","IE00BN8TJ469.HKD","SG9999014542.SGD","IE00BK4W5M84.HKD","LU1934455863.HKD","CMAG","LU2125154935.USD","SGXZ31699556.SGD","SG9999018865.SGD","LU0553294199.USD","CHPX","IE00B4JS1V06.HKD","NBIS","ILDR","IE00BK4W5L77.USD","07788","LU2237443895.HKD","TEK","LU1935043536.SGD","LU1201861249.SGD","LU1989772923.USD","NVD3.UK","LU1489326972.SGD","LU0353189680.USD","LU2097344431.USD","BK4504","LU0868494617.USD","BK4567","LU2237443382.USD","LU1496350171.SGD","IE0034235295.USD","IE00BJLML261.HKD","LU2394011477.USD","LU2322448791.USD","NVDW","HK0000306685.HKD","LU0056508442.USD","IE00BZ9MQY76.HKD","LU0211328371.USD","LU0234570918.USD","LU0276348264.USD","LU1400636491.USD","LU2237957811.SGD","NVDY","LU0314106906.USD","LU1548497426.USD","NVDG","LU0265550946.USD","AGOX","IXN","LU1551013342.USD","SG9999003800.SGD","LU0795875086.SGD","LU2125909759.SGD","SG9999014013.SGD","BK4547","BK4550","IE00BQXX3F31.USD","LU2191332357.HKD","LU1804176565.USD","LU2100268510.USD","LU0345768740.USD","BK4592","SG9999014880.SGD","LU0072462426.USD","LU0965509283.SGD","LU1035775433.USD","LU1712237335.SGD","ORCZ","AIPI","SNVDAmain","FTEC","LU0289961442.SGD","LU1037948541.HKD","LU0823411888.USD","LU0823431647.USD","LU2247934214.USD","SG9999014021.USD","LU0795875169.SGD","LU1629891620.HKD","LU0640476718.USD","LU1003077747.HKD","TTEQ","PLTD","IE00BQXX3D17.EUR","HK0000320264.USD","LU2361044949.HKD","LU2471134952.CNY","LU2491050154.USD","LU0143863198.USD","KMLI","LU1791710582.SGD","LU0329931090.USD","IE0004445239.USD","LU0158827948.USD","LU0395794307.EUR","BK4585","IE00BJTD4V19.USD","LU2265009873.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666567022","title":"Alkermes Announces Launch of 9TH Annual Alkermes Pathways Research Awards® Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666567022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666567022?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:00","pubTimestamp":1789038000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8WKBZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","PSIL","BK4139","ALKS","PSCH","MEDX","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FXH","WDNA","JDOC","SBIO","BBH","GSKH","NVIB","MNTL","AZNH","LFSC","HRTS","GNOM","LLYX","IBRN","MEDI","PBPH","GNMX","MDTX","BBP","IBB","MEDX","GDOC","GPCR","PJP","BME","BIB","CANC","FBT","CURE","FHLC","TBXU","IBBQ","PTH","IEIH","IDNA","RSPH","XPH","JHMH","FTXH","CNCR","APXH","PSCH","IBBJ","SURI","PINK","SYNB","HYLG","PBE","PSIL","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","MRNY","GSKH","FHLC","IBBQ","APXH","PSCH","HYLG","SURI","PSIL","GPCR","FTXH","LENZ","BBP","CURE","RSPH","PBPH","TBXU","AZNH","BIB","MEDI","GDOC","MEDX","BBH","IBB","NVIB","JHMH","LLYX","IBBJ","FBT","GNOM","HRTS","SYNB","JDOC","XPH","PINK","MNTL","MDTX","FXH","SBIO","LFSC","BME","PTH","PJP","CANC","WDNA","IBRN","GNMX","PBE","CNCR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}